Gene group 2 displayed a significant upregulation of E2F transcription activators (E2F1, E2F2, E2F3, and E2F6) [30] and tumor-specific transcription factors (MYCN [31], RUNX1 [32], and GABPB1 [33]) in advanced Rb. The gene discussed is E2F1; the disease is neoplasm.